Detalhe da pesquisa
1.
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial.
Lancet Oncol
; 23(12): 1571-1582, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36370716
2.
Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2â×â2 factorial, randomised phase 3 trial.
Lancet
; 385(9980): 1863-72, 2015 May 09.
Artigo
Inglês
| MEDLINE | ID: mdl-25740286
3.
Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer.
NPJ Breast Cancer
; 7(1): 82, 2021 Jun 28.
Artigo
Inglês
| MEDLINE | ID: mdl-34183674
4.
Second line trastuzumab emtansine following horizontal dual blockade in a real-life setting.
Oncotarget
; 11(22): 2083-2091, 2020 Jun 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32547706
5.
Vascular disrupting agents: a novel mechanism of action in the battle against non-small cell lung cancer.
Oncologist
; 14(6): 612-20, 2009 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-19474164
6.
Recent developments of targeted therapies in the treatment of non-small cell lung cancer.
Curr Drug Discov Technol
; 6(2): 91-102, 2009 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-19519336
7.
The optional approach of oncogene-addicted non-small cell lung cancer with brain metastases in the new generation targeted therapies era.
Transl Lung Cancer Res
; 8(6): 1134-1151, 2019 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-32010591
8.
New insights in drug development for the non-small cell lung cancer therapy.
Front Biosci
; 13: 5108-19, 2008 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-18508573
9.
Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Region (Southern Italy) focused on activity, efficacy and safety.
Mol Clin Oncol
; 9(3): 255-263, 2018 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-30155246
10.
Screening for lung cancer: New horizons?
Crit Rev Oncol Hematol
; 56(3): 311-20, 2005 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-15978829
11.
Gefitinib as salvage therapy in pretreated patients with advanced non-small cell lung cancer. Data from a compassionate use program.
Anticancer Res
; 24(3b): 1873-7, 2004.
Artigo
Inglês
| MEDLINE | ID: mdl-15274368
12.
Complete response of severe symptomatic bone marrow metastases from heavily pretreated breast cancer with a 3-weekly trastuzumab schedule. A clinical case.
Anticancer Res
; 24(1): 317-9, 2004.
Artigo
Inglês
| MEDLINE | ID: mdl-15015614
13.
Single agent vinorelbine as first-line chemotherapy in elderly patients with advanced breast cancer.
Anticancer Res
; 23(2C): 1657-64, 2003.
Artigo
Inglês
| MEDLINE | ID: mdl-12820437
14.
Is primary surgery for locally advanced/metastatic breast cancer a better choice than chemotherapic treatment?
Ann Ital Chir
; 85(4): 317-22, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25262749
15.
Chemotherapy of advanced NSCLC in the elderly.
Tumori
; 88(1 Suppl 1): S143-4, 2002.
Artigo
Inglês
| MEDLINE | ID: mdl-11989910
16.
Management of unfit older patients with advanced NSCLC.
Cancer Treat Rev
; 35(6): 517-21, 2009 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-19457617
17.
New avenues for second-line treatment of metastatic non-small-cell lung cancer.
Expert Rev Anticancer Ther
; 9(1): 115-24, 2009 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-19105711
18.
Erlotinib in non-small-cell lung cancer.
Expert Opin Pharmacother
; 8(15): 2579-92, 2007 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-17931092
19.
Sorafenib and sunitinib in the treatment of advanced non-small cell lung cancer.
Oncologist
; 12(2): 191-200, 2007 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-17296815
20.
Treatment of small cell lung cancer in the elderly.
Oncologist
; 10(6): 399-411, 2005.
Artigo
Inglês
| MEDLINE | ID: mdl-15967834